Community/Retail

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research, discusses the biggest factors that play a role in determining the likelihood that a patient will remain adherent to medications during care transitions.

Third-year pharmacy students at the Fairleigh Dickinson University (FDU) School of Pharmacy will soon attend sessions at The Medicines Company's patient simulation (Sim) lab.

The Kroger Co. family of stores is partnering with Feeding America and the country's dairy farmers and milk companies to encourage its shoppers to 'Pour It Forward' by donating nutrient-rich milk to families in need in their local communities.

Gregory Smith, PhD, has co-authored 14 technical papers and formal presentations and has been involved in informal presentations to clients and technologists on innovation and new product discovery.

The Convenient Care Association (CCA) is pleased to announce that Contemporary Clinic has become its official journal.

A generic equivalent to Bristol-Myers Squibb's entecavir (Baraclude) hepatitis B treatment has been approved by the FDA.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about information pharmacists should give patients on high-dose basal insulin.

In the recent past, bipolar disorder has been classified as the most costly mental illness.

Community pharmacists have the opportunity to identify patients at risk for opioid overdose.

Reasor's has installed automated defibrillators in every store.

Company officials have announced that Food City will once again provide the flu vaccine this immunization season.

Recognition as a health care provider continues to be elusive for pharmacists.

PCSK9 inhibitors offer a new treatment option for patients with inherited conditions that cause high LDL cholesterol.

The Drug Enforcement Administration (DEA) recently made an appearance at a state pharmacy board meeting to appease pharmacists' fears of a crackdown on pharmacies.

As pharmacy students head back to school, an American Association of Colleges of Pharmacy (AACP) infographic offers an informative look at the state of pharmacy education.

Pharmacy technicians should know the following new drugs and expanded indications approved by the FDA in August 2015.

Rico Powell, CPhT, shares his thoughts on the pharmacy technician's growing role in ensuring patient safety and improving health care outcomes.

The FDA has proposed adding a 4-letter suffix to the names of biosimilars to distinguish them from their biologic counterparts.

Multidose medication dispensing at discharge (MMDD) involves supplying products that have been partially used during hospitalization to ensure continuity of care.

The 340B Program "mega-guidance" just released by the Health Resources and Services Administration (HRSA) clarifies how patients can receive deeply discounted drugs.

Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, talks about the benefits and risks of aggressive glycemic controls.

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes may cause severe and disabling joint pain, the FDA has warned.

Adding Afrezza insulin inhalation powder to oral diabetes medications significantly reduces HbA1C in adults with poorly controlled type 2 diabetes.